With a history of language service leadership and innovation, they help providers make better decisions based on better information, resulting in better outcomes and satisfaction for Limited English Proficient and Deaf and Hard of Hearing patients. They don’t simply sell to hospitals, they partner with them.

With a history of language service leadership and innovation, they help providers make better decisions based on better information, resulting in better outcomes and satisfaction for Limited English Proficient and Deaf and Hard of Hearing patients. They don’t simply sell to hospitals, they partner with them.

Building and testing new genomic prediction tools is difficult. Developing a new PRS requires months of complex labor by a team of bioinformaticians. Datasets need to be brought together and curated, multiple complex methods need to be run, and the results compared and reported. Allelica’s DISCOVER and VALIDATE modules empower researchers to construct new PRS using either their own datasets or the resources of large biobanks. Allelica’s platform streamlines the entire polygenic risk scoring process: from genotype imputation, through PRS development and validation in multiple ancestries, to detailed reporting services.

Allelica has created a secure and trusted platform for Polygenic Risk Score analysis and reporting to equip health systems and clinical laboratories with cutting-edge tools to reduce the impact of common disease through genomic medicine. 

All processes performed on the Allelica platform are fully HIPAA and GDPR-compliant. ISO 13485 and ISO 9001 certifications guarantee that Allelica applies medical device quality management processes every step of the way.

Allelica is working with leading health systems and genetics laboratories in the United States and across Europe to advance disease prevention through widened application of PRS in healthcare.